CONMED Financial Statements From 2010 to 2025

CNMD Stock  USD 62.74  0.77  1.24%   
CONMED financial statements provide useful quarterly and yearly information to potential CONMED investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CONMED financial statements helps investors assess CONMED's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CONMED's valuation are summarized below:
Gross Profit
733 M
Profit Margin
0.1013
Market Capitalization
1.9 B
Enterprise Value Revenue
2.1199
Revenue
1.3 B
There are over one hundred nineteen available fundamental signals for CONMED, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of CONMED's prevailing performance against the performance from 2010 to 2025 to make sure the company is sustainable for few more years. The current year's Market Cap is expected to grow to about 3.9 B. The current year's Enterprise Value is expected to grow to about 819.6 M

CONMED Total Revenue

1.37 Billion

Check CONMED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CONMED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 75.4 M, Interest Expense of 39.2 M or Selling General Administrative of 210 M, as well as many indicators such as Price To Sales Ratio of 0.97, Dividend Yield of 0.0135 or PTB Ratio of 1.28. CONMED financial statements analysis is a perfect complement when working with CONMED Valuation or Volatility modules.
  
Check out the analysis of CONMED Correlation against competitors.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

CONMED Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.4 B2.3 B1.5 B
Slightly volatile
Short and Long Term Debt Total951.1 M905.8 M538 M
Slightly volatile
Other Current Liabilities183.9 M175.2 M102.3 M
Slightly volatile
Total Current Liabilities292 M278.1 M173.7 M
Slightly volatile
Total Stockholder EquityB962.7 M661.8 M
Slightly volatile
Property Plant And Equipment Net93.3 M115.8 M113.6 M
Very volatile
Net Debt925.4 M881.3 M506.1 M
Slightly volatile
Retained Earnings588.3 M560.3 M418.9 M
Slightly volatile
Cash17.4 M24.5 M30.6 M
Pretty Stable
Non Current Assets Total1.7 B1.7 B1.1 B
Slightly volatile
Non Currrent Assets Other122.2 M116.4 M68.8 M
Slightly volatile
Cash And Short Term Investments17.8 M24.5 M30.7 M
Pretty Stable
Net Receivables249.6 M237.7 M165.8 M
Slightly volatile
Common Stock Shares Outstanding26.1 M31.1 M27.7 M
Slightly volatile
Liabilities And Stockholders Equity2.4 B2.3 B1.5 B
Slightly volatile
Non Current Liabilities Total1.1 B1.1 B664.6 M
Slightly volatile
Inventory364.1 M346.7 M198.1 M
Slightly volatile
Other Current Assets32.7 M31.1 M21.2 M
Slightly volatile
Other Stockholder Equity484.3 M461.3 M288.6 M
Slightly volatile
Total Liabilities1.4 B1.3 B838.3 M
Slightly volatile
Property Plant And Equipment Gross442.3 M421.2 M206.4 M
Slightly volatile
Total Current Assets672 M640 M419.3 M
Slightly volatile
Short Term Debt679.2 K715 K14.6 M
Very volatile
Intangible Assets341.4 M617.7 M398.6 M
Slightly volatile
Accounts Payable107.4 M102.2 M50.5 M
Slightly volatile
Good Will445.9 M805.4 M451.6 M
Slightly volatile
Common Stock Total Equity317.6 K359.9 K302.9 K
Slightly volatile
Common Stock342 K359.9 K59.3 M
Slightly volatile
Other Liabilities312.3 M297.5 M135.3 M
Slightly volatile
Other Assets103.6 M98.7 M67.6 M
Slightly volatile
Long Term Debt950.3 M905.1 M543.2 M
Slightly volatile
Property Plant Equipment129.3 M133 M120.2 M
Very volatile
Retained Earnings Total Equity467.3 M474.5 M425.4 M
Slightly volatile
Long Term Debt Total1.2 B1.1 B557.3 M
Slightly volatile
Capital Surpluse384.5 M475.2 M361.8 M
Slightly volatile
Deferred Long Term Liabilities72.4 M60.1 M86.1 M
Slightly volatile
Non Current Liabilities Other70.3 M86.3 M63.4 M
Slightly volatile
Deferred Long Term Asset Charges5.7 M5.4 M3.6 M
Slightly volatile
Short and Long Term Debt679.2 K715 K10.4 M
Slightly volatile
Net Invested Capital1.7 B1.9 B1.4 B
Slightly volatile
Net Working Capital284.7 M361.9 M237.7 M
Slightly volatile
Capital Stock250.4 K281.7 K307.1 K
Slightly volatile
Capital Lease Obligations19.2 M20.5 M23.9 M
Slightly volatile

CONMED Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization75.4 M71.9 M51.6 M
Slightly volatile
Selling General Administrative210 M117.5 M313.3 M
Slightly volatile
Total Revenue1.4 B1.3 B870.7 M
Slightly volatile
Gross Profit769.7 M733 M474 M
Slightly volatile
Other Operating Expenses1.2 B1.1 B790.2 M
Slightly volatile
EBITDA285.8 M272.2 M122.2 M
Slightly volatile
Cost Of Revenue602.7 M574 M396.6 M
Slightly volatile
Total Operating Expenses242 M237.2 M355.2 M
Slightly volatile
Research Development29.4 M54.4 M35 M
Slightly volatile
Non Recurring48.2 M54.3 M59.2 M
Slightly volatile
Interest Income51.6 M49.1 M25.3 M
Slightly volatile
Reconciled Depreciation75.5 M71.9 M64.6 M
Slightly volatile
Extraordinary Items769.5 K810 K16.4 M
Slightly volatile
Selling And Marketing Expenses55.9 M58.8 M276.4 M
Slightly volatile

CONMED Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow161.6 M153.9 M68.3 M
Slightly volatile
Begin Period Cash Flow18.3 M24.3 M29.9 M
Very volatile
Depreciation15.8 M16.6 M48.3 M
Pretty Stable
Capital Expenditures17.5 M13.1 M16.2 M
Pretty Stable
Total Cash From Operating Activities175.3 M167 M84.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.971.61521.986
Slightly volatile
Dividend Yield0.01350.01170.0129
Slightly volatile
PTB Ratio1.282.19292.6081
Slightly volatile
Days Sales Outstanding74.9281.771.0305
Slightly volatile
Book Value Per Share32.7731.209323.0645
Slightly volatile
Free Cash Flow Yield0.0820.07290.0562
Slightly volatile
Operating Cash Flow Per Share5.685.4132.9238
Slightly volatile
Stock Based Compensation To Revenue0.02050.01960.013
Slightly volatile
Capex To Depreciation0.760.7880.3907
Pretty Stable
PB Ratio1.282.19292.6081
Slightly volatile
EV To Sales1.342.28952.4822
Slightly volatile
Free Cash Flow Per Share5.244.98882.366
Slightly volatile
Inventory Turnover2.451.65552.2746
Slightly volatile
Days Of Inventory On Hand138220167
Slightly volatile
Payables Turnover5.335.613610.1838
Slightly volatile
Sales General And Administrative To Revenue0.07680.08090.2837
Slightly volatile
Research And Ddevelopement To Revenue0.0310.04160.0406
Slightly volatile
Capex To Revenue0.00950.010.0198
Slightly volatile
Cash Per Share0.480.79291.089
Slightly volatile
POCF Ratio13.4612.643725.4963
Slightly volatile
Capex To Operating Cash Flow0.07440.07840.2366
Pretty Stable
PFCF Ratio14.413.718840.7157
Slightly volatile
Days Payables Outstanding68.2765.020342.4147
Slightly volatile
EV To Operating Cash Flow18.1817.922132.4171
Slightly volatile
EV To Free Cash Flow20.4219.44652.7676
Slightly volatile
Intangibles To Total Assets0.40.6170.5454
Slightly volatile
Net Debt To EBITDA5.033.23811.4925
Slightly volatile
Current Ratio4.12.30112.6825
Pretty Stable
Receivables Turnover4.534.625.1484
Slightly volatile
Graham Number57.6554.905427.6833
Slightly volatile
Shareholders Equity Per Share32.7731.209323.0645
Slightly volatile
Debt To Equity0.550.94090.7131
Slightly volatile
Capex Per Share0.490.42420.5609
Very volatile
Revenue Per Share44.4942.372330.3435
Slightly volatile
Interest Debt Per Share32.130.573819.1545
Slightly volatile
Debt To Assets0.230.39280.3093
Slightly volatile
Enterprise Value Over EBITDA18.6810.994246.608
Slightly volatile
Short Term Coverage Ratios22121059.5359
Slightly volatile
Operating Cycle191220232
Slightly volatile
Price Book Value Ratio1.282.19292.6081
Slightly volatile
Days Of Payables Outstanding68.2765.020342.4147
Slightly volatile
Price To Operating Cash Flows Ratio13.4612.643725.4963
Slightly volatile
Price To Free Cash Flows Ratio14.413.718840.7157
Slightly volatile
Company Equity Multiplier1.622.39572.1268
Slightly volatile
Long Term Debt To Capitalization0.280.48460.3744
Slightly volatile
Total Debt To Capitalization0.280.48480.3852
Slightly volatile
Debt Equity Ratio0.550.94090.7131
Slightly volatile
Quick Ratio1.01.05451.4247
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.94.42482.4583
Very volatile
Cash Ratio0.08350.08790.2321
Slightly volatile
Cash Conversion Cycle227155196
Pretty Stable
Operating Cash Flow Sales Ratio0.110.12770.095
Pretty Stable
Days Of Inventory Outstanding138220167
Slightly volatile
Days Of Sales Outstanding74.9281.771.0305
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.970.92160.7662
Pretty Stable
Cash Flow Coverage Ratios0.180.18430.2676
Slightly volatile
Price To Book Ratio1.282.19292.6081
Slightly volatile
Fixed Asset Turnover11.8511.28757.4944
Slightly volatile
Capital Expenditure Coverage Ratio13.412.76125.5294
Slightly volatile
Price Cash Flow Ratio13.4612.643725.4963
Slightly volatile
Enterprise Value Multiple18.6810.994246.608
Slightly volatile
Debt Ratio0.230.39280.3093
Slightly volatile
Cash Flow To Debt Ratio0.180.18430.2676
Slightly volatile
Price Sales Ratio0.971.61521.986
Slightly volatile
Asset Turnover0.810.56670.65
Slightly volatile
Gross Profit Margin0.420.56080.5314
Very volatile
Price Fair Value1.282.19292.6081
Slightly volatile

CONMED Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.9 B3.7 B3.8 B
Slightly volatile
Enterprise Value819.6 M780.6 M806.7 M
Slightly volatile

CONMED Fundamental Market Drivers

Forward Price Earnings27.027
Cash And Short Term Investments24.5 M

CONMED Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About CONMED Financial Statements

CONMED stakeholders use historical fundamental indicators, such as CONMED's revenue or net income, to determine how well the company is positioned to perform in the future. Although CONMED investors may analyze each financial statement separately, they are all interrelated. For example, changes in CONMED's assets and liabilities are reflected in the revenues and expenses on CONMED's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CONMED. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-9.4 M-9 M
Total Revenue1.3 B1.4 B
Cost Of Revenue574 M602.7 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.08  0.08 
Research And Ddevelopement To Revenue 0.04  0.03 
Capex To Revenue 0.01  0.01 
Revenue Per Share 42.37  44.49 
Ebit Per Revenue 0.15  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:
Check out the analysis of CONMED Correlation against competitors.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.028
Dividend Share
0.8
Earnings Share
4.25
Revenue Per Share
42.372
Quarterly Revenue Growth
0.058
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.